4/A
Changes in Ownership
ELITE PHARMACEUTICALS INC /NV/ Filed Acc 0001465826-12-000013
Options or other derivatives
- Chief Scientific Officer acquired 187.5 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
NIGALAYE ASHOK G · Chief Scientific Officer
Table II: Derivative
1 line| Date | Transaction | Shares | Price | Value | Exercise | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|
| 2012-06-29 | Grant or award : show line 1 in the form Series E Convertible Preferred Stock | +187.5 | $1,000.00 | $187,500 | $0.02 | 7,684,427 | 1,937.5 | I |
Loading xslF345X03/primary_doc.xml…